SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-13-021326
Filing Date
2013-04-11
Accepted
2013-04-11 16:04:41
Documents
8
Period of Report
2013-05-22
Effectiveness Date
2013-04-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A v340926_def14a.htm DEF 14A 768471
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_sucampo.jpg GRAPHIC 4669
4 GRAPHIC sig_ryuji-ueno.jpg GRAPHIC 1298
5 GRAPHIC sig_thomasj-knapp.jpg GRAPHIC 2286
6 GRAPHIC spacer.gif GRAPHIC 43
7 GRAPHIC v340926_pc1.jpg GRAPHIC 225233
8 GRAPHIC v340926_pc2.jpg GRAPHIC 217757
  Complete submission text file 0001144204-13-021326.txt   1392325
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33609 | Film No.: 13756326
SIC: 2834 Pharmaceutical Preparations